The eradication rates of 10-day sequential therapy and PPI-based triple therapy were 79.3 % ( 92/116 ) and 63 % ( 82/130 ) by intention-to-treat analysis , respectively ( P = 0.005 ) , and 81.9 % ( 91/111 ) and 64.5 % ( 82/127 ) by per protocol analysis , respectively ( P = 0.003 ) .
